Related Experiment Videos

Respiratory syncytial virus pneumonia ventilated with high-frequency oscillatory ventilation

S Medbø1, P H Finne, T W Hansen

  • 1Department of Pediatrics, Rikshospitalet University Hospital, Oslo, Norway.

Insights

High-frequency oscillatory ventilation successfully treated four infants with respiratory syncytial virus (RSV) requiring mechanical ventilation. None ultimately needed extracorporeal membrane oxygenation, and most survived without lung damage.

Area of Science:

  • Pediatrics
  • Critical Care Medicine
  • Respiratory Medicine

Background:

  • Respiratory Syncytial Virus (RSV) infection is a common cause of severe respiratory illness in infants.
  • Assisted mechanical ventilation is often required for infants with severe RSV bronchiolitis.
  • Extracorporeal membrane oxygenation (ECMO) is a rescue therapy for severe respiratory failure but carries significant risks.

Observation:

  • Four infants under 6 months with confirmed RSV infection required mechanical ventilation.
  • High-frequency oscillatory ventilation (HFOV) was initiated as the primary ventilatory support.
  • Two infants met criteria for potential ECMO support during HFOV treatment.

Findings:

  • All four infants were successfully managed with HFOV without requiring ECMO.
  • All infants survived the acute illness.
  • Three out of four infants showed no apparent pulmonary sequelae post-treatment.

Implications:

  • HFOV may be an effective and potentially safer alternative to ECMO in select infants with severe RSV.
  • Early and appropriate application of HFOV could improve outcomes in critically ill infants with RSV.
  • Further research is warranted to define the role of HFOV in pediatric respiratory failure.

Related Concept Videos